Please ensure Javascript is enabled for purposes of website accessibility

Sick of Loud Ads on Netflix? A Proposed California Law Turns Down the Volume

7 hours ago

Fresno Airport Director Henry Thompson Dies. He Led Major Expansion

8 hours ago

Record Numbers of Americans Say Immigration Is Good for Country: Gallup Poll

9 hours ago

In California Strawberry Fields, Immigration Raids Sow Fear

10 hours ago

Trump to Send Weapons to Ukraine, Threatens Secondary Sanctions on Russia in 50 Days

10 hours ago

Newsom’s Office Attacks Stephen Miller, Calling Him a ‘Fascist Cuck’

11 hours ago

Trump’s Spending Bill Will Likely Boost Costs for Insurers, Shrink Medicaid Coverage

11 hours ago

American Allies Want to Redraw the World’s Trade Map, Minus the US

12 hours ago

Trump Says He Spoke to FBI’s Bongino Amid Epstein Uproar

12 hours ago
UC Davis Uses Antiviral Drug Remdesivir on 'Very Grave' COVID-19 Patient. She's Home Now.
TLBBHMAP3-U010ALB5ANM-348f959abae2-512-300x300-1
By Jim Jakobs, Digital Producer
Published 5 years ago on
April 1, 2020

Share

UC Davis Medical Center received the first case of community transmission of COVID-19 in the U.S. on Feb. 26. Within 24 hours of admission, the female patient’s respiratory status deteriorated.
Because of the severity of her illness, the team received approval from the Food and Drug Administration to treat the woman who is in her 40s with an investigational drug called remdesivir. She has since been discharged and is recovering at home.

Portrait of UC Davis Health professor Angela Haczku, M.D., Ph.D.
“They (the infectious disease doctors) feel that this drug saved the patient’s life.” — Angela Haczku, M.D., Ph.D., UC Davis
The team emphasizes that whether remdesivir is effective against human COVID-19 is not yet known.  Clinical trials funded by the National Institutes of Health and the pharmaceutical industry will be key to analyzing the drug’s effectiveness against coronavirus.
The broad-spectrum antiviral developed by Gilead Sciences Inc. has been tested in humans with Ebola and has shown promise against coronaviruses in animal models according to UC Davis.

What Is Remdesivir and How It Works

Gilead Sciences has initiated two Phase 3 clinical studies to evaluate the safety and “efficacy” of remdesivir in adults diagnosed with COVID-19 following the FDA’s rapid review and acceptance of Gilead’s investigational new drug filing.
“Studies began enrolling patients in March 2020 and will enroll a total of approximately 1,000 patients in the initial phase of the studies, in countries with high prevalence of COVID-19,” Gilead said in an email to GV Wire. “Remdesivir is an experimental medicine that does not have established safety or efficacy for the treatment of any condition.”
Here is a little more information about remdesivir from Gilead’s website:

  • In response to the Ebola outbreaks in West Africa in recent years, Gilead increased the manufacturing of remdesivir to create a stockpile that could be used for future pandemics, as well as a stockpile of the materials used to manufacture remdesivir.
  • Gilead is now using this stockpile to address the supply needed for current compassionate-use requests and ongoing clinical trials.

An article published in The Scientist, a magazine for life science professionals, discusses remdesivir in the following manner:
“Researchers led by Vanderbilt University’s Mark Denison and the University of North Carolina at Chapel Hill’s Ralph Baric showed in 2017 that remdesivir could inhibit replication of the coronaviruses that cause both severe acute respiratory syndrome (SARS) and MERS in human lung cells. The authors also found that the drug reduced viral load and improved respiratory function in a mouse model of SARS.”

Remdesivir Clinical Trials

In a news release, Allison Brashear, dean of the UC Davis School of Medicine said, “Given the urgent need to find an effective treatment for COVID-19, clinical trials are essential for determining, from a scientific standpoint, if remdesivir is safe and effective. With this new study funded by the NIH, UC Davis will be an important contributor to these critical efforts.”


Q&A With UC Davis Professor About the Use of Remdesivir

GV Wire spoke with Angela Haczku MD, Ph.D., of UC Davis to gain insight into what this could mean for other COVID-19 patients. She is the Professor of Medicine Associate Dean for Translational Research.
GV Wire: “How was the patient when she first arrived at the hospital?
“The patient’s status was very, very grave. At the time, when the doctors were desperately trying to help her, this drug worked very well for her. So, I think within a day or two, the course of the disease turned around.”
“Do you think that the drug helped her or do you think it was just absolute blind luck?”
“They (the infectious disease doctors) feel that this drug saved the patient’s life.”
“In California, can the governor approve remdesivir as a treatment without waiting for FDA approval?”
“I know it is a possibility. … I am very very hopeful that very soon we will have this resolved, and very soon we will have some treatment approved (by the FDA) for this disease.”
“By soon, do you mean months or do you mean sooner?”
“I would say one (month), but maybe not too many … could say maybe weeks.”
UC Davis Health has written a paper that’s now published in Clinical Infectious Diseases about their findings.
[covid-19-tracker]

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Max Fire Near Pine Flat Lake Grows to 426 Acres. Evacuations Remain in Place

DON'T MISS

Vendors Demand Arias Resign Over False ICE Raid Warning. He Says Trump Is the Culprit

DON'T MISS

Fresno Unified Rewards Incompetence? Ex-Comms Chief Could Get Huge Severance

DON'T MISS

Elmo’s X Account Gets Hacked, Posts Antisemitic and Racist Messages

DON'T MISS

3-Year-Old Dies After Drowning in Backyard Pool in Porterville

DON'T MISS

Meta Investors, Zuckerberg to Square off at $8 Billion Trial Over Alleged Privacy Violations

DON'T MISS

MAGA Is Tearing Itself Apart Over Jeffrey Epstein

DON'T MISS

Fresno Grass Fire Burns Along Veterans Boulevard, Under Investigation

DON'T MISS

Trump to Unveil $70 Billion in AI and Energy Investments

DON'T MISS

Fire at Boston-Area Senior Living Facility Kills at Least Nine

UP NEXT

Fire at Boston-Area Senior Living Facility Kills at Least Nine

UP NEXT

Arizona Governor Wants Investigation of Federal Handling of Grand Canyon Fire

UP NEXT

Sick of Loud Ads on Netflix? A Proposed California Law Turns Down the Volume

UP NEXT

Woman Airlifted After Injury on Madera County’s Lewis Creek Trail

UP NEXT

Record Numbers of Americans Say Immigration Is Good for Country: Gallup Poll

UP NEXT

In California Strawberry Fields, Immigration Raids Sow Fear

UP NEXT

Trump to Send Weapons to Ukraine, Threatens Secondary Sanctions on Russia in 50 Days

UP NEXT

Newsom’s Office Attacks Stephen Miller, Calling Him a ‘Fascist Cuck’

UP NEXT

Trump’s Spending Bill Will Likely Boost Costs for Insurers, Shrink Medicaid Coverage

UP NEXT

US Judge Grants Trump Admin Request to Scrap Biden-Era Medical Debt Rule

Elmo’s X Account Gets Hacked, Posts Antisemitic and Racist Messages

4 hours ago

3-Year-Old Dies After Drowning in Backyard Pool in Porterville

5 hours ago

Meta Investors, Zuckerberg to Square off at $8 Billion Trial Over Alleged Privacy Violations

5 hours ago

MAGA Is Tearing Itself Apart Over Jeffrey Epstein

5 hours ago

Fresno Grass Fire Burns Along Veterans Boulevard, Under Investigation

6 hours ago

Trump to Unveil $70 Billion in AI and Energy Investments

6 hours ago

Fire at Boston-Area Senior Living Facility Kills at Least Nine

6 hours ago

Arizona Governor Wants Investigation of Federal Handling of Grand Canyon Fire

6 hours ago

Egypt Says Israel-EU Agreement Has Not Increased Aid to Gaza

7 hours ago

US Supreme Court Clears Way for Trump to Gut Education Department

7 hours ago

Max Fire Near Pine Flat Lake Grows to 426 Acres. Evacuations Remain in Place

A wildfire burning near Pine Flat Lake has scorched 426 acres and remains just 5% contained as of Monday, according to CalFire. Dubbed the M...

3 hours ago

The Max Fire near Pine Flat Lake has burned 427 acres, is 5% contained, and continues to prompt evacuation orders in the Blue Canyon area as of Monday, July 14, 2025. (CalFire)
3 hours ago

Max Fire Near Pine Flat Lake Grows to 426 Acres. Evacuations Remain in Place

4 hours ago

Vendors Demand Arias Resign Over False ICE Raid Warning. He Says Trump Is the Culprit

4 hours ago

Fresno Unified Rewards Incompetence? Ex-Comms Chief Could Get Huge Severance

Elmo speaks at The Wall Street Journal's Future of Everything Festival in New York City, U.S., May 22, 2024. (Reuters/Andrew Kelly)
4 hours ago

Elmo’s X Account Gets Hacked, Posts Antisemitic and Racist Messages

5 hours ago

3-Year-Old Dies After Drowning in Backyard Pool in Porterville

Meta CEO Mark Zuckerberg looks on before the luncheon on the inauguration day of U.S. President Donald Trump's second Presidential term in Washington, U.S., January 20, 2025. (Reuters File)
5 hours ago

Meta Investors, Zuckerberg to Square off at $8 Billion Trial Over Alleged Privacy Violations

5 hours ago

MAGA Is Tearing Itself Apart Over Jeffrey Epstein

6 hours ago

Fresno Grass Fire Burns Along Veterans Boulevard, Under Investigation

Help continue the work that gets you the news that matters most.

Search

Send this to a friend